Literature DB >> 6376357

In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes.

O V Gadeberg, I Orskov.   

Abstract

The cytotoxic effect of Escherichia coli bacteria on human blood granulocytes was measured by recording numbers of nonlysed cells and percentages of viable cells after in vitro incubation with bacteria in the presence of plasma. A total of 179 strains from various sources of infection were tested. Of 117 alpha-hemolytic strains, 59 were cytotoxic. Five nonhemolytic mutant strains, derived from alpha-hemolytic cytotoxic strains, were nontoxic. None of the 62 nonhemolytic strains were toxic. Four spontaneously occurring alpha-hemolytic, nontoxic mutant strains were isolated from cytotoxic ones. Cytotoxicity of bacteria reached a maximum after log-phase growth at 30 to 37 degrees C for 2.5 h, and the toxic capacity was equal after growth in various media, including human urine and plasma. The cytotoxic effect increased with the length of exposure of granulocytes to bacteria and with increasing numbers of bacteria per granulocyte. Cytotoxic strains showed different degrees of toxicity, highly cytotoxic strains lysing about 90% of the granulocytes and killing about one-half of nonlysed cells in 1 h. Bacteria killed by heat, formaldehyde, or UV light were nontoxic. Alpha-hemolytic strains of O groups 2, 4, 6, 25, and 75 originating from various infections in humans were more frequently cytotoxic than alpha-hemolytic strains of other O groups derived from human infections. Culture supernatants containing free alpha-hemolysin were highly cytotoxic to human blood granulocytes, monocytes, and lymphocytes in vitro, whether supernatants originated from cytotoxic or noncytotoxic bacteria. Cytotoxicity to phagocytes, which is mediated by or closely linked genetically to alpha-hemolysin, may be a mechanism by which alpha-hemolytic strains of E. coli strengthen their ability to establish and maintain infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376357      PMCID: PMC263309          DOI: 10.1128/iai.45.1.255-260.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

2.  The effect of iron compounds on the virulence of Escherichia coli for guinea-pigs.

Authors:  J J Bullen; L C Leigh; H J Rogers
Journal:  Immunology       Date:  1968-10       Impact factor: 7.397

3.  The effect of iron and transferrin on the killing of Escherichia coli in fresh serum.

Authors:  J Fletcher
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  Effect of iron on the bactericidal proteins from rabbit polymorphonuclear leukocytes.

Authors:  G P Gladstone; E Walton
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

5.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

6.  Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates.

Authors:  B H Minshew; J Jorgensen; G W Counts; S Falkow
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

7.  Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans.

Authors:  B H Minshew; J Jorgensen; M Swanstrum; G A Grootes-Reuvecamp; S Falkow
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

8.  Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.

Authors:  S J Cavalieri; I S Snyder
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

9.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Effects of a single hit from the alpha hemolysin produced by Escherichia coli on the morphology of sheep erythrocytes.

Authors:  S E Jorgensen; R F Hammer; G K Wu
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more
  38 in total

1.  Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles.

Authors:  C Hyland; L Vuillard; C Hughes; V Koronakis
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

2.  Partial purification of alpha-hemolysin in Escherichia coli.

Authors:  F Nistiar; V Janigová; J Durovicová; H Puzová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 3.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

4.  Identification of RTX toxin target cell specificity domains by use of hybrid genes.

Authors:  C Forestier; R A Welch
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 5.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

Review 6.  Bacterial hemolysins as virulence factors.

Authors:  W Goebel; T Chakraborty; J Kreft
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

7.  Nucleotide sequence of an Escherichia coli chromosomal hemolysin.

Authors:  T Felmlee; S Pellett; R A Welch
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

8.  A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.

Authors:  Michael D Engstrom; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

9.  Cytotoxic activity of the Proteus hemolysin HpmA.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.

Authors:  S Bhakdi; E Martin
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.